<DOC>
	<DOC>NCT00487526</DOC>
	<brief_summary>Study the effect of Duodenal jejunal bypass on human adults with type 2 diabetes.</brief_summary>
	<brief_title>Duodenal Jejunal Bypass for Type 2 Diabetes (DJBD)</brief_title>
	<detailed_description>Adults non obese ( BMI less than 34 ) will undergo duodenal jejunal bypass. The Outcome measures: Blood Sugar, Insulin,HbA1c, CCK,Gastrin, GIP1and 2, Ghrelin, Cholesterol, Triglycerides,FFA, C-Peptide.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Adults age 2065 Clinical diagnosis of type 2 diabetes Non obese with BMI less than 34. Oral agents or insulin to control T2DM. Inadequate control of diabetes as defined as HbA1c&gt;/7.5 Understanding of the mechanisms of action of the treatment Children with type 1 diabetes Obese with BMI over 34 Coagulopathy Liver cirrhosis Unable to comply with study requirements, followup or give valid consent Currently pregnant Previous upper abdominal surgery Inabilty to tolerate general anesthesia</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Bypass</keyword>
	<keyword>Duodenal jejunal</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>non-obese adults</keyword>
</DOC>